SmartPeople: Dr Gillian Burgess - PharmaTimes Magazine June 2018
- Magazine Article - PharmaTimes
by Selina McKee
https://www.pharmatimes.com/magazine/2018/june_2018/smartpeople_dr_gillian_burgess- Magazine Article - PharmaTimes
by Selina McKee
https://www.pharmatimes.com/magazine/2018/june_2018/smartpeople_dr_gillian_burgessTakeda has revealed that it is considering making a move on Shire to add ballast to its core therapeutic areas. - News - PharmaTimes
by Selina McKee
https://www.pharmatimes.com/news/takeda_eyes_up_shire_1229776The deadline for entering the 2020 PharmaTimes Communications Awards, Sales Awards and Marketer of the Year competitions has been extended to Friday October 2 after a last-minute spike in enquiries - News - PharmaTimes
by Selina McKee
https://www.pharmatimes.com/news/shine_bright_in_2020!_1350504US regulators have turned down Amgen's request to market Parsabiv for secondary hyperparathyroidism (sHPT). - News - PharmaTimes
by Selina McKee
https://www.pharmatimes.com/news/fda_rejects_amgens_parsabiv_1110551AstraZeneca has sold off certain rights to its antipsychotics Seroquel and Seroquel XR in certain territories - including the UK – to Luye Pharma. - News - PharmaTimes
by Selina McKee
https://www.pharmatimes.com/news/astrazeneca_sheds_seroquel_rights_1234663- News - PharmaTimes
by Selina McKee
https://www.pharmatimes.com/news/gsk_to_file_shingles_jab_this_year_1132946Swiss drugs giant Roche is rejoining the Association of the British Pharmaceutical Industry after cutting ties with the trade body seven years ago. - News - PharmaTimes
by Selina McKee
https://www.pharmatimes.com/news/roche_rejoins_apbi_1119375European regulators have approved Vifor Pharma’s new potassium binder Veltassa to treat hyperkalaemia in adult patients. - News - PharmaTimes
by Selina McKee
https://www.pharmatimes.com/news/eu_nod_for_vifors_veltassa_1199011This year's competition welcomed a fantastic spread of companies as well as a higher number of entrants - News - PharmaTimes
by Selina McKee
https://www.pharmatimes.com/news/pharmatimes_unveils_winners_of_msea_2019_1319263GW Pharmaceuticals and its US subsidiary Greenwich Biosciences have completed the rolling submission of Epidiolex as adjunctive treatment of seizures associated with Lennox-Gastaut syndrome and Dravet syndrome, two difficult-to-treat forms of
by Selina McKee
https://www.pharmatimes.com/news/gw_completes_epidiolex_submission_1209905